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Background: People who inject drugs (PWID) use healthcare services, including primary care, at a
disproportionately high rate. We investigated key correlates of general practitioner (GP) related service utilisation
within a cohort of PWID.
Methods: Using baseline data from a cohort of 645 community-recruited PWID based in Melbourne, Victoria, we
conducted a secondary analysis of associations between past month use of GP services unrelated to opioid
substitution therapy (OST) and socio-demographic and drug use characteristics and self-reported health using
multivariate logistic regression.
Results: Just under one-third (29%) of PWID had accessed GP services in the month prior to being surveyed.
Participants who reported living with children (adjusted odds ratio, AOR 1.97, 95% CI 1.04 - 3.73) or having had
contact with a social worker in the past month (AOR 1.92, 95% CI 1.24 - 2.98) were more likely to have seen a GP in
the past month. Participants who were injecting daily or more frequently (AOR 0.50, 95% CI 0.30 - 0.83) or had a
weekly income of less than $400 (AOR 0.59, 95% CI 0.38 - 0.91) were less likely to report having seen a GP in the
past month.
Conclusions: Our sample frequently attended GP services for health needs unrelated to OST. Findings highlight
both the characteristics of PWID accessing GP services and also those potentially missing out on primary care and
preventive services.
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People who inject drugs (PWID) are at elevated risk of
acute and chronic health conditions including dermato-
logic disease, pulmonary and respiratory complications,
psychiatric illness, gastrointestinal illness, genitourinary
disease, blood-borne viruses (BBV), circulatory compli-
cations, asthma, diabetes mellitus and hypertension [1-4].
These conditions can be exacerbated further by the social
conditions commonly experienced by PWID such as
homelessness, unemployment, lack of financial and social
support, violence and stigma and discrimination [5]. Per-
sonal characteristics such as age also relate to risk, with* Correspondence: dhanya@burnet.edu.au
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unless otherwise stated.young and new initiates to injecting more likely to borrow
and lend used injecting equipment and practice unsafe
sex, and less likely to test for BBVs compared to older,
more experienced PWID [6]. While these risk exposures
and health conditions indicate elevated need for health
services, the patterns and types of health services used by
PWID remain unclear in the Australian context. A recent
Australian study reported general practitioners (GPs) the
most commonly accessed health service in the past year
(64%), followed by PWID-specific primary health care
services and emergency services [7]. While rates of GP ac-
cess in this study were comparable to use in the general
Australian population, almost half the study population
was on opioid substitution therapy (OST) and the average
age of participants was 37 years old. Previous research
indicates that older PWID are more likely to engagel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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All service access 306 (47.4) 33 (5.1) 63 (9.8) 243 (37.7)
GP-related services 155 (24.0) 20 (3.1) 14 (2.2) 456 (70.7)
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tunity to study younger PWID in Australia within this
context.
The social, health and political contexts of injecting
drug use means access to health services by PWID can
be appropriately positioned within the Behavioural Mo-
del of Andersen and Newman [10]. This well-validated
model shows health service utilisation as underpinned
by barriers and enablers, and mediated by individuals’
need for care [11]. Although an individual’s perceived
need for health care drives motivation to use health ser-
vices, other factors influence actual utilisation. These
predisposing characteristics may include demographic
features, health beliefs, social structure, substance use,
personal, family and community resources, and factors
related to perceived need. Among PWID, factors such as
prioritising social needs above health needs, self-perceived
health, reluctance to disclose drug use and distrust of ser-
vice providers, social isolation, transport, service delivery
models, and punitive measures around child welfare
[2,12-14] have been identified as factors that might ‘pre-
dispose’ GP service utilisation. These barriers may under-
pin the delays in accessing primary health services [2] and
related frequent use of emergency services [15], as well as
low continuity of care [16].
In Victoria, the majority of primary care delivered to
PWID is facilitated through GP services [17]. To address
access barriers associated with traditional GP services
and provide or facilitate referral to targeted services to
meet the specific needs of PWID, primary health care
services that cater specifically to PWID were introduced
in Victoria in 1999 [18,19]. Located in traditional street
drug market “hotspots” in Melbourne, Victoria has five
such state-funded free clinics providing primary health
care and harm reduction services (including Needle/Syr-
inge Exchange Programs (NSP) and, at some locations,
Opioid Substitution Therapy (OST) prescribed by GPs).
The objective of these services was to enable a coordi-
nated and comprehensive primary health care response
to enhance the health and welfare of PWID who were
reluctant to utilise mainstream services [19]. The pri-
mary health care setting provides a contact opportunity
and service system entry point with this otherwise hard-
to-reach population where they can be identified and en-
gaged in harm reduction [20-22]. Distinguishing between
dependence-related GP services (primarily opioid substi-
tution therapy) and general health services serves to
understand if PWID who are not accessing OST have
sufficient access to preventive health services provided
by GPs.
Drawing from broader literature around health service
utilisation among PWID, our study was designed to exa-
mine factors associated with access to general health ser-
vices through GP service utilisation among a cohort ofyoung PWID in Melbourne with a view to understand-
ing the barriers and enablers to service access.
Methods
A sample of PWID was recruited between November
2008 and March 2010 in Melbourne, Australia as part of
the Melbourne Injecting Drug User cohort study (MIX)
that has been described in detail elsewhere [23]. Briefly,
participants were individuals aged between 18 and 30
years old (these age criteria included to focus on newer,
younger initiates into injecting drug use than those typ-
ically recruited in studies of Australian PWID e.g. [24]),
who reported injecting either heroin or methamphet-
amines at least monthly over the previous six months
and were able to provide a valid Medicare card number.
The purpose of the study was to examine trajectories of
injecting drug use among PWID. Participants were re-
cruited using a combination of Respondent Driven Sam-
pling (RDS), street outreach and snowball sampling to
ensure maximum participation and representativeness.
Participants completed a researcher-administered ques-
tionnaire that covered socio-demographics, drug use and
drug market access, health and social functioning and
health service utilisation. Validated instruments included
the AUDIT-C [25], the Personal Wellbeing Index [26,27]
as well as the SF8 Health Survey [28]. Participants were
reimbursed AUD$30 in cash for their time and out-of-
pocket expenses in completing the questionnaire. The
study was approved by the Human Research Ethics Com-
mittee of the Victorian Department of Health and Monash
University Human Research Ethics Committee.
Measures
Based on the concept of utilisation as one component of
healthcare access [29,30], we measured exposures at the
individual level associated with utilisation of GP-related
services. GP-related service utilisation was defined as
accessing a GP in the past month at either general or
PWID-specific health centres (Table 1). The outcome vari-
able was derived from asking participants if they had ac-
cessed general GP and/or PWID-specific primary health
care services in the past month. This was followed by a
description of what services were used, such as drug de-
pendence or other services. PWID-specific primary health
care services were located in settings that also provi-
ded NSP, counselling, allied health, community, welfare
and justice services as well as referrals. Participants who
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what services they received during their visit, allowing the
identification of service contacts at PWID-specific primary
care services that were GP-related. Relevant GP-related
descriptions included attendance for wound care and in-
juries, BBVs, pregnancy, general health visits and health
referrals. General GP settings may also provide drug de-
pendence services such as OST. OST visits that were con-
current with primary health care visits at either general or
PWID-specific primary health care services were included
in the analysis but services accessed exclusively for drug
dependence (including OST) were not included.
Exposure variables explored as correlates of GP service
utilisation, described in Table 1, were selected based on
previous literature on health-related outcomes within
the study population [31,32] and those related to a revi-
sion of the Behavioral Model of Andersen and Newman
for Vulnerable Populations [33]. Low income was de-
fined as a weekly income below $400; the mean income
of low income households [34].
Analysis
Using logistic regression, we explored the bivariate asso-
ciation between past month use of GP services and a
range of exposure variables. Associations significant at
the p < 0.1 level in bivariate analysis were then included
in a multivariate logistic regression model to identify
independent correlates of GP service uptake (p < 0.05).
Multicollinearity among variables included in the final
model was examined and all Variance Inflation Factors
(VIF) were within acceptable limits. Model fit was ex-
amined using Pearson chi-square goodness-of-fit test.
Age, gender and concurrent OST were included in all
final models on an a priori basis. Analysis was con-
ducted using Stata 11.1 (Statacorp LP, Texas, USA).
Results
Sample characteristics
Of the 688 people in the study, 43 did not have complete
data on GP service utilisation in the past month and
were excluded from the analysis. The remaining 645 re-
spondents were largely male (67%) and born in Australia
(81%). Over half of the sample was aged between 25 and
29 years with a median of 27 years. Unstable accommo-
dation (e.g., boarding houses, squatting, homelessness)
was reported by 19% of the sample and 34% had less
than Year 10 education. The majority of participants
(81%) fell within the Australian Bureau of Statistics [35]
definition of low income. Over 80% of respondents re-
ported heroin injection in the past month and 53% re-
ported arrest in the past 12 months. More than half of
participants (59%) were recruited through snowball sam-
pling, with an additional 38% through RDS and the re-
maining 3% through outreach.Of those reporting a testing history (92% for hepatitis
C and 88% for HIV) and knowing their results, 52% re-
ported a positive hepatitis C result and 1% reported a
positive HIV result. Approximately 44% of participants
reported at least one general health problem such as
asthma, a current sexually transmitted infection, sleep-
ing difficulties, or mental health problems. The mean
self-perceived wellbeing of the sample as measured by
the Personal Wellbeing Index was 54.3 (SD 19.0), some
twenty points lower than the Australian population
mean of 75.4 (SD 12.8) [36].Service utilisation
There were 402 (62%) participants who accessed either
general GP or PWID-specific primary health care set-
tings in the past month (Table 1). These services include
both OST and GP-related services. Among the 645 par-
ticipants reporting on GP utilisation, 29% had at least
one visit to a GP for a health-related reason in the past
month that was unrelated to OST, defined as a GP-
related service. Most (82%) GP-related visits occurred
in general clinic settings. The majority (69%) of respon-
dents who had not visited a GP in the past month did not
access hospital, emergency, ambulance, dental, specialist
or other services in the past month either.Factors associated with GP service utilisation
Table 2 summarises the results of the regression analyses
for variables included in this study. Socio-demographic
characteristics were only significantly associated with GP
service utilisation at the bivariate level, where partici-
pants who were female, employed and living with chil-
dren were more likely to report GP access. In contrast
those born in Vietnam (compared to Australia) and from
non-English speaking backgrounds were less likely to re-
port GP access in the past month. Of note was the rela-
tionship between use of other health services and access
to GP services. Although the association was not signifi-
cant in the final model, the bivariate trends indicated
that respondents who used multiple health services were
likely to have used GP services as well.
Few associations remained significant in the multivar-
iate analysis. Low socioeconomic status, as indexed by
low income, and frequent injecting (characterised by in-
jecting at least daily) were associated with a lower likeli-
hood of GP service utilisation, after adjusting for other
variables listed in Table 1. In contrast, living with chil-
dren and past month contact with a social worker were
both associated with an increased likelihood of GP con-
tact. Although having ever been tested for a BBV was
significant in the final model, it was removed due to
multicollinearity (VIF 7.61). The final model showed a
low level of multicollinearity (overall VIF = 1.78).
Table 2 Correlates of GP service use in the past montha
Variable n (%) Unadjusted OR Adjusted ORb
(95% CI) (95% CI)
Female 210 (32.6) 1.84 (1.29 – 2.62) 1.30 (0.86 – 1.98)
Employed 85 (13.2) 1.86 (1.16 – 2.97) 1.44 (0.82 – 2.55)
Low income group 526 (81.5) 0.50 (0.33 – 0.75) 0.50 (0.30 – 0.83)
Current stable accommodation 514 (79.7) 0.96 (0.62 – 1.46) -
Education
<Year 10 219 (33.9) 1.29 (0.88 – 1.89) -
Year 10-11 (ref) 292 (45.3) 1 -
Year 12 or higher 134 (20.8) 1.21 (0.77 – 1.90) -
Failure at school 193 (29.9) 0.99 (0.69 – 1.44) -
Living with children 57 (8.8) 2.37 (1.36 – 4.10) 1.97 (1.04 – 3.73)
Country of birth
Australia (ref) 522 (80.9) 1 1
Vietnam 46 (7.13) 0.33 (0.14 – 0.79) 0.72 (0.24 – 2.14)
Other 77 (11.9) 0.77 (0.45 – 1.33) 0.98 (0.53 – 1.82)
Non-English speaking background 94 (14.6) 0.45 (0.25 – 0.79) 0.79 (0.38 – 1.62)
Identify as Aboriginal or Torres Islander 38 (5.9) 0.98 (0.47 – 2.02) -
Age at interview
<20 34 (5.3) 2.0 (0.98 – 4.12) 1.75 (0.80 – 3.84)
20-24 153 (23.7) 1.1 (0.70 – 1.62) 1.02 (0.65 – 1.62)
25-29 (ref) 330 (51.1) 1 1
> = 30 128 (19.8) 1.0 (0.63 – 1.57) 0.92 (0.56 – 1.51)
Prison – ever 382 (59.2) 0.94 (0.66 – 1.32) -
Length of injecting career (years) 10.1 (median) 1.00 (0.96 – 1.04) -
Injected heroin - past month 527 (81.7) 0.84 (0.55 – 1.30) -
Injected methamphetamines - past month 203 (31.5) 1.25 (0.87 – 1.79) -
Used benzodiazepines - past month 350 (54.3) 1.25 (0.89 – 1.76) -
Injected daily or more 191 (29.6) 0.56 (0.38 – 0.84) 0.59 (0.38 – 0.91)
Tested for Hepatitis C / HIV - ever 594 (92.1) 2.35 (1.08 – 5.11) -
Experienced barrier/s to accessing treatment 72 (11.2) 1.63 (0.98 – 2.70) 1.28 (0.73 – 2.27)
Currently on OST 222 (34.4) 1.10 (0.77 – 1.57) 0.94 (0.63 – 1.41)
Number of other health services used - past month
None 422 (65.4) 0.68 (0.46 – 0.99) 0.88 (0.58 – 1.35)
Less than 3 (ref) 178 (27.6) 1 1
3 or more 45 (7.0) 2.30 (1.19 – 4.47) 1.88 (0.93 – 3.80)
Social/ welfare worker contact - past month 133 (20.6) 2.43 (1.63 – 3.60) 1.92 (1.24 – 2.98)
Heroin overdose – 6 months 63 (9.8) 0.88 (0.49 – 1.58) -
Intentional overdose - ever 73 (11.3) 2.19 (1.34 – 3.60) 1.59 (0.91 – 2.78)
AUDIT-C score (0 – 11)
abstinent (ref) 228 (35.4) 1 11.33 (0.85 – 1.86)
<8 292 (45.3) 1.74 (1.17 – 2.57) 1.10 (0.63 – 1.91)
> = 8 124 (19.2) 1.49 (0.91 - 2.44)
SF8 Physical wellbeing score poor (45 or below) 194 (30.1) 1.47 (1.02 – 2.11) 1.22 (0.80 – 1.86)
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Table 2 Correlates of GP service use in the past montha (Continued)
SF8 Mental wellbeing score poor (45 or below) 317 (49.1) 1.57 (1.12 – 2.22) 1.07 (0.71 – 1.62)
Personal Wellbeing Index score 55 (median) 0.99 (0.98 – 1.00) -
One or more general health conditions 336 (52.1) 1.76 (1.24 – 2.49) 1.38 (0.93 – 2.05)
aResults are from logistic regression with a final model comprising 645 observations.
bAOR reported for exposures significant (p < .1) at the bivariate level which did not exhibit multicollinearity in the final model (overall VIF = 1.78,
Pearson chi-square p = .271).
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In this study we have examined GP-related general health
service utilisation among PWID. By distinguishing this
from primary care attendances exclusively related to drug
dependence treatment (including OST), this is the first
study to examine factors associated with non-OST related
primary care utilisation among a cohort of Australian
PWID. Approximately a third of our sample reported
accessing a GP for a general health issue in the previous
month. While our data are not directly comparable due to
the younger age distribution of the study population, it
would appear that our sample of Australian PWID fre-
quent GPs more often than the general population [37].
Given that over half of participants reported one or more
health conditions, and almost half rated their health and
wellbeing poorly, there is clearly a need for non-OST re-
lated primary care. This need would be expected to in-
crease over time due to ageing and exacerbation of health
issues associated with long term drug use. Examining po-
tential barriers and enablers to service use will contribute
towards identifying subpopulations who have limited ac-
cess to GP-related services.
Our participants with an income below the Australian
population average, were considerably less likely to ac-
cess general health services as compared to those with
higher incomes. This finding, consistent with other in-
ternational research that shows low income is negatively
associated with doctor contact [38,39], was evident des-
pite the universal coverage of health services in Australia
and the availability of free services for PWID. Countries
with similar health systems see more primary care ser-
vice use among lower socioeconomic groups [40,41],
suggesting that there may be systematic differences be-
tween PWID and the general population that influence
health service utilisation. In this health systems context,
low income may be a marker of the impact of other is-
sues such as the geographic access, cost of transport and
competing priorities such as obtaining regular meals that
we did not measure. The complex vulnerabilities associ-
ated with low income, which affects a large proportion
of PWID, influences the priority that health takes and
consequently the use of health services [42].
Our findings indicate that participants who reported
injecting daily or more frequently were almost half as
likely to access GPs. More frequent injecting is associa-
ted with more severe dependence [43], lower uptake ofOST [8,44] and longer time to injecting cessation [43].
Daily injecting has also been associated with multiple and
serious injecting-related injuries and diseases [2,45] which
are common among PWID in Australia [45]. Despite these
risks, the more frequent injectors in our study were less
likely to access GP services. While these data suggest that
they may be accessing hospital [46] or other services for
these complications, we did not observe a significant cor-
relation between frequent injecting and use of emergency
or hospital inpatient or outpatient services (data not
shown). As such, the healthcare needs of high frequency
injectors in our study may remain unmet.
In contrast with the common view of chaotic drug use
[47], parenting can represent a point of stability in the
lives of PWID [42]. Our study suggests that participants
who lived with children were twice as likely to report
GP access compared to those who did not. This is consist-
ent with literature around the increased sense of responsi-
bility associated with having children, and the importance
PWID place in regular monitoring of their children by
health service providers, although this is not always the
case [48,49]. However, as the purpose of the visit (if it
was for the child or themselves) was not recorded, we
were limited in our interpretation of the data beyond ac-
cess to services. Collaborative services which attend to
the needs of parent and child may encourage better up-
take of services [50] and increased likelihood that health
needs are met. Further research into the impact of ha-
ving children on health service utilisation and the po-
tential opportunities provided by more frequent health
systems contacts for drug using parents and their chil-
dren is required.
Contact with a social worker in the past month was
associated with an increased likelihood of GP service
utilisation. PWID access social services for a range of is-
sues such as homelessness and mental health problems
[51]. Contact with social services may occur through re-
ferral by GPs, conversely, social services may refer PWID
to primary care [52,53], meaning that the causal pathway
of service access is unclear. Irrespective, the increased
likelihood of contact with a GP associated with social wor-
ker access indicates that social workers may be an effective
gateway to comprehensive health services for an otherwise
hard to reach population.
This study is limited firstly by the self-report data used
which may be subject to recall and social acceptability
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sentativeness of this cohort, and hence the generaliz-
ability of these findings. In addition, the distinction
between GPs situated at general and targeted services
may have been subject to some misclassification as visits
to PWID-specific primary care centres were included
on the basis of descriptive text and each visit could
include a range of activities, meaning that some GP-
related visits may have been missed. However this is
also an advantage as descriptive text contextualises the
reason for the service use and has been provided by the
recipient of the service. Future studies of PWID primary
care need to clarify the purposes of all GP visits. We
are limited in interpreting the causal pathway between
the exposures and outcomes due to the cross-sectional
nature of this study, for example if physical and mental
wellbeing would increase access to GP-related sevices,
or vice versa. We plan to address these gaps using
longitudinal analysis.Conclusions
Building on broader research around health service utili-
sation among PWID, our study focuses on general health
services as a principal element in determining health
outcomes for this population. The strength of this re-
search lies in the sample itself who are a relatively young
cohort of actively injecting PWID, the majority of whom
were out of treatment at baseline and may have different
health needs and service utilisation patterns compared
to other injecting populations previously studied e.g.
[7,55]. Given the high rates of GP service utilisation, the
health needs of this population are not limited to opioid
dependence, and consequently health service needs ex-
tend beyond OST. Ensuring PWID have access to health
services early in their injecting career could prevent
chronic conditions prevalent among their older coun-
terparts [56]. It may also reduce the use of emergency
services for health needs that could be addressed in pri-
mary care settings [57]. Key findings from this study are
that low socioeconomic status and frequent injecting
practices impair GP service utilisation within this popula-
tion. The former is particularly notable; providing health-
care cards to PWID of low socioeconomic status may not
be sufficient to support access to services. Comprehensive
services and support can alleviate the pressures faced by
this population and create an environment conducive to
harm minimisation strategies. Further research using lon-
gitudinal data from this cohort will serve to understand
health service utilisation trends and supplement our
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